Edgewise Therapeutics, Inc. (EWTX)

SEC filing

Edgewise Therapeutics, Inc.

EWTX · CIK 1710072

4 · Aug 14, 2026 · Director, President and CEO KOCH KEVIN sold 17.97K shares at $43.68/share ($785.0K); exercised options for 79.69K shares; was granted 300K shares

Director, President and CEO KOCH KEVIN sold 17.97K shares at $43.68/share ($785.0K); exercised options for 79.69K shares; was granted 300K shares

Filed: Aug 14, 2026
Period: Aug 12, 2026
Accession: 0001185829-26-000001
Filer: Edgewise Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

PRIMARY DOCUMENT

xslF345X06/primarydocument.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4PRIMARY DOCUMENTprimarydocument.xml
Open SEC.gov